Venus Injectoplast Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 29-07-2024
- Paid Up Capital ₹ 1.96 M
as on 29-07-2024
- Company Age 15 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 16.35 Cr
as on 29-07-2024
- Revenue 19.31%
(FY 2023)
- Profit 48.78%
(FY 2023)
- Ebitda 31.48%
(FY 2023)
- Net Worth 16.33%
(FY 2023)
- Total Assets 11.40%
(FY 2023)
About Venus Injectoplast
The Corporate was formerly known as Novapax Venus Polymers Private Limited. The Company is engaged in the Automotive Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.96 M.
The company currently has active open charges totaling ₹16.35 Cr.
Dinesh Jindal and Yaman Jindal serve as directors at the Company.
- CIN/LLPIN
U25200HR2009PTC038861
- Company No.
038861
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Mar 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Faridabad, Haryana, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Venus Injectoplast Private Limited offer?
Venus Injectoplast Private Limited offers a wide range of products and services, including Product Engineering and Prototyping, Product Designing, Die Casting Mould & Moulding Tools, Injection Moulds, Molding Machines, Injection Molding Machines.
Who are the key members and board of directors at Venus Injectoplast?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dinesh Jindal  | Director | 06-Mar-2009 | Current |
| Yaman Jindal | Director | 29-Aug-2019 | Current |
Financial Performance of Venus Injectoplast.
Venus Injectoplast Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 19.31% increase. The company also saw a substantial improvement in profitability, with a 48.78% increase in profit. The company's net worth Soared by an impressive increase of 16.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Venus Injectoplast?
In 2023, Venus Injectoplast had a promoter holding of 75.00% and a public holding of 25.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 26 Apr 2024 | ₹11.00 Cr | Open |
Bank Of India Creation Date: 02 Jun 2021 | ₹4.80 M | Open |
Bank Of India Creation Date: 10 Feb 2020 | ₹2.37 M | Open |
How Many Employees Work at Venus Injectoplast?
Venus Injectoplast has a workforce of 37 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Venus Injectoplast, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Venus Injectoplast's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
